Carl Zeiss Meditec ups FY core profit guidance, shares soar
BERLIN, April 12 (Reuters) - German medical technology company Carl Zeiss Meditec raised its full-year core profit outlook on Friday, sending shares higher.
The margin for earnings before interest and taxes (EBIT) is now expected to reach 15 to 17.5 percent, up from a previous guidance of 14 to 16 percent.
Shares in the company, which were included in Germany's midcap MDAX index in December, were up 6.2 percent at 0822 GMT.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.